What Researchers Did
Researchers used decision analysis to compare a hyperbaric oxygen chamber to current therapy for treating decompression sickness on the International Space Station.
What They Found
The hyperbaric oxygen chamber strategy was associated with a net cost saving of $12.5 million and reduced the likelihood of premature shuttle and Soyuz returns by 8% and 3%, respectively.
What This Means for Canadian Patients
This research suggests that implementing a hyperbaric oxygen chamber on the ISS could improve safety and reduce costs for astronauts, including Canadians involved in space missions. Such a facility would offer a more effective treatment for decompression sickness, potentially preventing serious health complications and mission disruptions.
Canadian Relevance
This study has direct Canadian relevance as inputs for the decision model were derived from consultations with personnel at the Canadian Space Agency. Canadian researchers were also involved in the study, contributing to the analysis of costs and benefits for space missions.
Study Limitations
A key limitation is that the study's results are sensitive to the assumed lifespan of the International Space Station.